Iralukast

DB20883ExperimentalSmall molecule

Iralukast is a small molecule drug. The usage of the INN stem '-lukast' in the name indicates that Iralukast is a leukotriene receptor antagonist. Iralukast has a monoisotopic molecular weight...

Formula / weight: C₃₈H₃₇F₃O₈S · 710.76 g/mol (avg)

Resolves to

Compound

UNIIL1E28E0J8FCAS151581-24-7ChEMBLCHEMBL1206833ChEBI749627PubChem6913104

Structure

InChIKeyIXJCHVMUTFCRBH-SDUHDBOFSA-NSMILESCCCC1=C(OCCCC\C=C/C=C/[C@H](SC2=CC=C3C(=O)C=C(OC3=C2)C(O)=O)[C@H](O)C2=CC(=CC=C2)C(F)(F)F)C=CC(C(C)=O)=C1O

Targets

Q9Y271CYSLTR1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Iralukast, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account